Early Menopause Can Predict Heart and Vascular Disease
|
By HospiMedica International staff writers Posted on 17 Oct 2019 |
A new study suggests that women who reach menopause before the age of 50 have an increased risk of cardiovascular disease (CVD).
Researchers at the University of Queensland (UQ; Brisbane, Australia), Karolinska Institutet (KI; Solna, Sweden), the University of Hawaii (Hilo, USA), and other institutions conducted a study to assess the associations between age at natural menopause and incidence and timing of CVD. To do so, they pooled individual-level data from 15 observational studies across five countries and regions between 1946 and 2013. The primary endpoint was the occurrence of first non-fatal CVD, adjusted to account for smoking status, menopausal hormone therapy status, body mass index (BMI), and education levels.
Age at natural menopause was categorized as premenopausal or perimenopausal, younger than 40 years (premature menopause), 40-44 years (early menopause), 45-49 years (relatively early), 50-51 years (reference category), 52-54 years (relatively late), and 55 years or older (late menopause). Women who underwent a hysterectomy or oophorectomy and those women who did not report their age at menopause were excluded from analysis. In all, 301,438 women were included in the meta-analysis.
The results revealed that 4.3% of the women had a first non-fatal CVD event after menopause, of which 3.1% had coronary heart disease (CAD), and 1.4% had a stroke. Risk of CVD was higher in women who had premature menopause, early menopause, and relatively early menopause, with a considerably reduced risk of CVD following menopause after age 51 years. Associations persisted in never smokers, and were strongest before age 60 years for women, but were attenuated at age 60-69 years, with no significant association observed at age 70 years and older. The study was published on October 3, 2019, in Lancet Public Health.
“Identifying women with early menopause offers a window of opportunity for their doctors to work with them to monitor and actively manage cardiovascular disease risk factors,” said lead author Dongshan Zhu, PhD, of the UQ School of Public Health. “The findings will have important clinical and public health implications. Early clinical diagnosis will help to improve overall cardiovascular health in women in their postmenopausal years.”
Menopause describes the permanent cessation of the primary functions of the human ovaries, including cessation of estradiol and progesterone production, which are a part of the body's endocrine system of hormone production. After menopause, estrogen continues to be produced in other tissues, notably the ovaries, but also in bone, blood vessels and even in the brain; but a dramatic fall in circulating estradiol levels at menopause impacts many tissues, from bone to brain to skin.
Related Links:
University of Queensland
Karolinska Institutet
University of Hawaii
Researchers at the University of Queensland (UQ; Brisbane, Australia), Karolinska Institutet (KI; Solna, Sweden), the University of Hawaii (Hilo, USA), and other institutions conducted a study to assess the associations between age at natural menopause and incidence and timing of CVD. To do so, they pooled individual-level data from 15 observational studies across five countries and regions between 1946 and 2013. The primary endpoint was the occurrence of first non-fatal CVD, adjusted to account for smoking status, menopausal hormone therapy status, body mass index (BMI), and education levels.
Age at natural menopause was categorized as premenopausal or perimenopausal, younger than 40 years (premature menopause), 40-44 years (early menopause), 45-49 years (relatively early), 50-51 years (reference category), 52-54 years (relatively late), and 55 years or older (late menopause). Women who underwent a hysterectomy or oophorectomy and those women who did not report their age at menopause were excluded from analysis. In all, 301,438 women were included in the meta-analysis.
The results revealed that 4.3% of the women had a first non-fatal CVD event after menopause, of which 3.1% had coronary heart disease (CAD), and 1.4% had a stroke. Risk of CVD was higher in women who had premature menopause, early menopause, and relatively early menopause, with a considerably reduced risk of CVD following menopause after age 51 years. Associations persisted in never smokers, and were strongest before age 60 years for women, but were attenuated at age 60-69 years, with no significant association observed at age 70 years and older. The study was published on October 3, 2019, in Lancet Public Health.
“Identifying women with early menopause offers a window of opportunity for their doctors to work with them to monitor and actively manage cardiovascular disease risk factors,” said lead author Dongshan Zhu, PhD, of the UQ School of Public Health. “The findings will have important clinical and public health implications. Early clinical diagnosis will help to improve overall cardiovascular health in women in their postmenopausal years.”
Menopause describes the permanent cessation of the primary functions of the human ovaries, including cessation of estradiol and progesterone production, which are a part of the body's endocrine system of hormone production. After menopause, estrogen continues to be produced in other tissues, notably the ovaries, but also in bone, blood vessels and even in the brain; but a dramatic fall in circulating estradiol levels at menopause impacts many tissues, from bone to brain to skin.
Related Links:
University of Queensland
Karolinska Institutet
University of Hawaii
Latest Patient Care News
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







